CTXR logo

Citius Pharmaceuticals (CTXR) Selling, General & Administrative Expenses

Annual SGA

$30.09 M
+$8.18 M+37.32%

September 30, 2024


Summary


Performance

CTXR SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTXRexpensesmetrics:

Quarterly SGA

$8.14 M
+$265.30 K+3.37%

September 30, 2024


Summary


Performance

CTXR Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTXRexpensesmetrics:

TTM SGA

-$743.42 M
-$39.14 M-5.56%

September 30, 2024


Summary


Performance

CTXR TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTXRexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

CTXR Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+37.3%+3.4%-2646.3%
3 y3 years+166.5%+3.4%-2646.3%
5 y5 years+329.8%+3.4%-2646.3%

CTXR Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+166.5%at high+120.3%-96.8%at low
5 y5-yearat high+329.8%at high+356.2%-248.8%at low
alltimeall timeat high>+9999.0%at high>+9999.0%<-9999.0%at low

Citius Pharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
$30.09 M(+37.3%)
$8.14 M(+3.4%)
$30.09 M(+3.1%)
Jun 2024
-
$7.87 M(+6.9%)
$29.20 M(+11.3%)
Mar 2024
-
$7.36 M(+9.6%)
$26.23 M(+5.7%)
Dec 2023
-
$6.72 M(-7.2%)
$24.83 M(+13.3%)
Sep 2023
$21.91 M(+39.9%)
$7.24 M(+47.6%)
$21.91 M(+19.3%)
Jun 2023
-
$4.91 M(-17.6%)
$18.36 M(+5.0%)
Mar 2023
-
$5.96 M(+56.6%)
$17.48 M(+11.6%)
Dec 2022
-
$3.80 M(+3.0%)
$15.66 M(+0.0%)
Sep 2022
-
$3.69 M(-8.3%)
$15.66 M(+5.3%)
Sep 2022
$15.66 M(+38.7%)
-
-
Jun 2022
-
$4.03 M(-2.7%)
$14.88 M(+1.7%)
Mar 2022
-
$4.14 M(+8.9%)
$14.63 M(+11.4%)
Dec 2021
-
$3.80 M(+30.7%)
$13.13 M(+16.3%)
Sep 2021
$11.29 M(+26.9%)
$2.91 M(-23.1%)
$11.29 M(+2.3%)
Jun 2021
-
$3.78 M(+43.4%)
$11.04 M(+18.7%)
Mar 2021
-
$2.64 M(+34.2%)
$9.30 M(+2.4%)
Dec 2020
-
$1.97 M(-25.9%)
$9.08 M(+2.0%)
Sep 2020
$8.90 M(+27.1%)
$2.65 M(+29.7%)
$8.90 M(+12.9%)
Jun 2020
-
$2.04 M(-15.4%)
$7.88 M(+5.1%)
Mar 2020
-
$2.42 M(+35.5%)
$7.50 M(+6.8%)
Dec 2019
-
$1.78 M(+8.8%)
$7.03 M(+0.3%)
Sep 2019
$7.00 M(-3.1%)
$1.64 M(-1.3%)
$7.00 M(-3.9%)
Jun 2019
-
$1.66 M(-14.5%)
$7.29 M(+6.1%)
Mar 2019
-
$1.94 M(+10.4%)
$6.86 M(+8.1%)
Dec 2018
-
$1.76 M(-8.5%)
$6.35 M(-12.1%)
Sep 2018
$7.23 M
$1.92 M(+55.2%)
$7.23 M(-0.1%)
Jun 2018
-
$1.24 M(-13.2%)
$7.23 M(-10.2%)
Mar 2018
-
$1.43 M(-45.9%)
$8.06 M(-3.1%)
DateAnnualQuarterlyTTM
Dec 2017
-
$2.64 M(+36.7%)
$8.31 M(+17.9%)
Sep 2017
$7.05 M(+56.1%)
$1.93 M(-6.6%)
$7.05 M(+6.7%)
Jun 2017
-
$2.06 M(+22.6%)
$6.61 M(+5.1%)
Mar 2017
-
$1.68 M(+22.6%)
$6.29 M(+14.8%)
Dec 2016
-
$1.37 M(-7.4%)
$5.47 M(+21.2%)
Sep 2016
$4.52 M(+215.2%)
$1.48 M(-15.0%)
$4.52 M(+33.7%)
Jun 2016
-
$1.75 M(+100.2%)
$3.38 M(+69.6%)
Mar 2016
-
$871.90 K(+109.8%)
$1.99 M(+37.7%)
Dec 2015
-
$415.50 K(+20.0%)
$1.45 M(+1.0%)
Sep 2015
$1.43 M(+4999.3%)
$346.20 K(-3.4%)
$1.43 M(+31.9%)
Jun 2015
-
$358.20 K(+9.6%)
$1.09 M(+48.9%)
Mar 2015
-
$326.70 K(-18.7%)
$729.80 K(+61.1%)
Dec 2014
-
$401.80 K(>+9900.0%)
$452.90 K(+254.9%)
Jun 2014
-
$1300.00(-97.4%)
$127.60 K(-1.6%)
Mar 2014
-
$49.80 K(-19.4%)
$129.70 K(+45.4%)
Dec 2013
-
$61.80 K(+320.4%)
$89.20 K(+218.6%)
Sep 2013
$28.10 K(+43.4%)
$14.70 K(+332.4%)
$28.00 K(+57.3%)
Jun 2013
-
$3400.00(-63.4%)
$17.80 K(-13.6%)
Mar 2013
-
$9300.00(+1450.0%)
$20.60 K(+14.4%)
Dec 2012
-
$600.00(-86.7%)
$18.00 K(-8.2%)
Sep 2012
$19.60 K(-23.4%)
$4500.00(-27.4%)
$19.60 K(+12.0%)
Jun 2012
-
$6200.00(-7.5%)
$17.50 K(-4.9%)
Mar 2012
-
$6700.00(+204.5%)
$18.40 K(-2.1%)
Dec 2011
-
$2200.00(-8.3%)
$18.80 K(-26.6%)
Sep 2011
$25.60 K
$2400.00(-66.2%)
$25.60 K(+10.3%)
Jun 2011
-
$7100.00(0.0%)
$23.20 K(+44.1%)
Mar 2011
-
$7100.00(-21.1%)
$16.10 K(+78.9%)
Dec 2010
-
$9000.00
$9000.00

FAQ

  • What is Citius Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals annual SGA year-on-year change?
  • What is Citius Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals quarterly SGA year-on-year change?
  • What is Citius Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Citius Pharmaceuticals?
  • What is Citius Pharmaceuticals TTM SGA year-on-year change?

What is Citius Pharmaceuticals annual SGA?

The current annual SGA of CTXR is $30.09 M

What is the all time high annual SGA for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high annual SGA is $30.09 M

What is Citius Pharmaceuticals annual SGA year-on-year change?

Over the past year, CTXR annual SGA has changed by +$8.18 M (+37.32%)

What is Citius Pharmaceuticals quarterly SGA?

The current quarterly SGA of CTXR is $8.14 M

What is the all time high quarterly SGA for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high quarterly SGA is $8.14 M

What is Citius Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, CTXR quarterly SGA has changed by +$265.30 K (+3.37%)

What is Citius Pharmaceuticals TTM SGA?

The current TTM SGA of CTXR is -$743.42 M

What is the all time high TTM SGA for Citius Pharmaceuticals?

Citius Pharmaceuticals all-time high TTM SGA is -$39.10 K

What is Citius Pharmaceuticals TTM SGA year-on-year change?

Over the past year, CTXR TTM SGA has changed by -$772.62 M (-2646.35%)